Altimmune’s (ALT) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. They currently have a $12.00 price objective on the stock. Several other research firms have also recently commented on ALT. Stifel Nicolaus assumed coverage on Altimmune in a research note […]
HC Wainwright reaffirmed their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. They currently have a $12.00 price objective on the stock. Several other research firms have also recently commented on ALT. Stifel Nicolaus assumed coverage on Altimmune in a research note […]